Joshua F. Zeidner's profile photo

Joshua F. Zeidner

Featured in: Favicon nature.com Favicon frontiersin.org Favicon tandfonline.com Favicon medpagetoday.com Favicon bloodjournal.org Favicon onclive.com

Articles

  • A second look at the status quo for secondary acute myeloid leukemia after hypomethylating agents

    2 weeks ago | acsjournals.onlinelibrary.wiley.com | Daniel Peters |Joshua F. Zeidner

    CONFLICT OF INTEREST STATEMENT Joshua F. Zeidner reports consulting or advisory roles for AbbVie, AstraZeneca, Daiichi Sankyo, Foghorn, Genmab, Gilead, Neogenomics, Novartis, Sellas, Servier, Shattuck Labs, Sumitomo Pharma, and Syndax; and research funding from AbbVie, Akesobio, Arog, AstraZeneca, Faron, Gilead, Jazz, Loxo, Merck, Newave, Novartis, Sellas, Shattuck Labs, Stemline, Sumitomo Pharma, and Zentalis. The other author declares no conflicts of interest.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →